Extended biopsy protocol decreases prostate cancer incidence and risk of aggressive disease on repeated biopsies compared with initial standard procedure

Urologia Internationalis

Volumn 84, Issue 2, 2010, Pages 147-152

  Ploussard, Guillaume ^a   Bastien, Laurence ^a   Descazeaud, Aurélien ^a   Robert, Grégoire ^a   Allory, Yves ^a   Salomon, Laurent ^a   Vordos, Dimitri ^a   Hoznek, Andreas ^a   Yiou, René ^a   Abbou, Claude Clément ^a   De La Taille, Alexandre ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Detection rate; Prostate cancer; Repeat biopsy; Saturation biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REPEAT PROCEDURE; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL PROLIFERATION; HUMANS; INCIDENCE; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK;

EID: 77949359481     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000277590     Document Type: Article

References (27)

1. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM: Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol 2004; 171: 1089-1092.
2. de la Taille A, Antiphon P, Salomon L, Cherfan M, Porcher R, Hoznek A, Saint F, Vordos D, Cicco A, Yiou R, Zafrani ES, Chopin D, Abbou CC: Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003; 61: 1181-1186.
3. Presti JC Jr, O'Dowd GJ, Miller MC, Mattu R, Veltri RW: Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003; 169: 125-129.
4. Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F: Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007; 52: 1309-1322.
5. Guichard G, Larré S, Gallina A, Lazar A, Faucon H, Chemama S, Allory Y, Patard JJ, Vordos D, Hoznek A, Yiou R, Salomon L, Abbou CC, de la Taille A: Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1,000 consecutive patients. Eur Urol 2007; 52: 430-435.
6. Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006; 175: 485-488.
7. Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS: Saturation technique does not decrease cancer detection during follow-up after initial prostate biopsy. J Urol 2008; 179: 1746-1750.
8. Eskew LA, Bare RL, McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199-202.
9. Elabbady AA, Khedr MM: Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol 2006; 49: 49-53.
10. Eskew LA, Woodruff RD, Bare RL, McCullough DL: Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol 1998; 160: 794-796.
11. Walz J, Graefen M, Chun FK, Erbersdobler A, Haese A, Steuber T, Schlomm T, Huland H, Karakiewicz PI: High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006; 50: 498-505.
12. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL: Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000; 163: 158-162.
13. Pepe P, Aragona F: Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 2007; 70: 1131-1135.
14. Mian BM, Naya Y, Okihara K, Vakar-Lopez F, Troncoso P, Babaian RJ: Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 2002; 60: 836-840.
15. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006; 175: 1605-1612.
16. Sajadi KP, Kim T, Terris MK, Brown JA, Lewis RW: High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. Urology 2007; 70: 691-695.
17. Epstein JI, Walsh PC, Akingba G, Carter HB: The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. J Urol 1999; 162: 1649-1652.
18. Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ: The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management. J Urol 2005; 174: 2164-2168.
19. Numao N, Kawakami S, Yokoyama M, Yonese J, Arisawa C, Ishikawa Y, Ando M, Fukui I, Kihara K: Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol 2007; 52: 1663-1668.
20. Descazeaud A, Rubin M, Chemama S, Larré S, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Chopin D, Abbou C, de la Taille A: Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen. World J Urol 2006; 24: 676-680.
21. Master VA, Chi T, Simko JP, Weinberg V, Carroll PR: The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol 2005; 174: 1789-1793.
22. Meng MV, Elkin EP, DuChane J, Carroll PR: Impact of increased number of biopsies on the nature of prostate cancer identified. J Urol 2006; 176: 63-68.
23. Chan TY, Chan DY, Stutzman KL, Epstein JI: Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol 2001; 166: 2181-2184.
24. Herawi M, Kahane H, Cavallo C, Epstein JI: Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. J Urol 2006; 175: 121-124.
25. Satoh A, Matsumoto K, Nakamura S: Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies? Int J Urol 2006; 13: 224-227.
26. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM: Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol 2004; 171: 1850-1854.
27. Lopez-Corona E, Ohori M, Wheeler TM, Reuter VE, Scardino PT, Kattan MW, Eastham JA: Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. J Urol 2006; 175: 923-927.